Developing immune-based therapies for blood cancers [ 2014 - ]

Research Grant

Researchers: Dr Stephen Mattarollo (Principal investigator)

Brief description Patients with lymphoma cancers initially respond well to treatment, but later relapse with disease. The immune system can be effective at controlling cancer. A potential treatment option is to boost the natural immune response against cancer. This study investigates a novel vaccine that activates a certain immune cell, NKT cells, to fight lymphomas by delivering an NKT cell-activating molecule. Outcomes will allow assessment of combining an NKT-based vaccine with established treatments for lymphoma.

Funding Amount $404,884.00

Funding Scheme Career Development Fellowships

Notes RD Wright Biomedical CDF